[{"source": "https://www.youtube.com/feeds/videos.xml?channel_id=UCF9IOB2TExg3QIBupFtBDxg", "title": "Spain, convincing therapeutic evidence", "description": "Effect of calcifediol treatment and best available therapy versus best available therapy on intensive care unit admission and mortality among patients hospitalized for COVID-19: A pilot randomized clinical study (October 2020)\n\nhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7456194/\n\nn = 76, Calcifediol treatment\n\n50 patients treated with calcifediol\n\nOne required admission to ICU (2%)\n\nNo deaths\n\n26 untreated patients\n\n13 required admission to ICU (50 %)\n\n2 deaths\n\nCalcifediol treatment and COVID-19-related outcomes\n\n(22nd January)\n\nBarna-COVIDIOL\n\nBarcelona\n\nhttps://papers.ssrn.com/sol3/papers.cfm?abstract_id=3771318\n\n \n\nEffect of calcifediol treatment\n\nIn admitted patients\n\nOn ICU admission\n\nand mortality\n\nN = 930\n\nRandomly assigned\n\nCalcifediol treatment group n = 551\n\nDay one, 532 ug (21,000 iu)\n\nDays, 3, 7, 15, 30, 266 ug (10,640 iu)\n\nNo adverse effects reported\n\nRequired ICU, 30 (5.4%) \n\nDeaths, 36 (6.5%)\n\nDeath RR = 0.36\n\n64% reduced chance of death\n\nControl group n = 379\n\nRequired ICU, 80 (21.1%), p less than 0.0001\n\nDeaths, 57 (15%), p = 0.001\n\n\nAdjusted for\n\nAge\n\nSex\n\nComorbidities\n\nLinearized 25(OH)D levels at baseline\n\nTreated patients\n\nReduced risk to require ICU\n\nRR 0.18\n\nBaseline 25(OH)D levels\n\nInversely correlated with the risk of ICU\n\nPredictors of reduced mortality\n\nHigher baseline 25(OH)D levels\n\nPredictors on increased mortality\n\nAge\n\nObesity\n\nInterpretation\n\nIn patients hospitalized with COVID-19, calcifediol treatment at the time of hospitalization significantly reduced ICU admission and mortality.\n\nEarly calcifediol after admission\n\nPrior to ARDS development, is critical for mortality reduction\n\nInitiation of calcifediol during ICU admission did not modify patient survival", "link": "https://www.youtube.com/watch?v=oYK9-zvJF_k", "date_published": "2021-02-13 00:00:00+00:00", "persistent": false, "user": null, "language": "en-US"}, {"source": "https://www.youtube.com/feeds/videos.xml?channel_id=UCF9IOB2TExg3QIBupFtBDxg", "title": "Vitamin D, blood levels", "description": "Vitamin D tests used in this video\n\nYour personalised vitamins\n\n\nhttps://www.yourpersonalisedvitamins.co.uk/\n\nSingle test, \u00a339.99\n\nYear plan, 2 tests and vitamin D supplies to titrate, \u00a375\n\nBetterYou test\n\n\u00a332.95\n\nhttps://betteryou.com/products/vitamin-d-test-kit?gclid=CjwKCAiA65iBBhB-EiwAW253W3gPTuiL_PONPgYXrj3XYbNv5vs43vvcc8mwv6gHPckgEqEnxPyMGBoCGUUQAvD_BwE\n\n\nVitamin D into the body\n\nD3 (cholecalciferol), sun, animals or supplement \n\nD2 (ergocalciferol), plants, supplements\n\nPathway\n\nIn the skin\n\nVitamin D, cholecalciferol, synthesised in the skin\n\nIn the liver\n\nConverted to its major circulating form, 25-hydroxyvitamin D (25(OH)D)\n\nCalcifediol \n\nIn the kidneys\n\nConverted into 1,25-dihydroxyvitamin D3, or calcitriol, the principal active hormonal form of vitamin D \n\nVitamin D in the blood\n\n25 hydroxy vitamin D\n\n25-hydroxyvitamin D (25OHD)\n\nCalcifediol \n\nCirculating concentration of 25OHD is the accepted biomarker for vitamin D status\n\n \nhttps://medlineplus.gov/ency/article/003569.htm\n\nMany experts recommend a level between 20 and 40 ng/mL (50 to 100 nmol/L)\n\nOthers recommend a level between 30 and 50 ng/mL (75 to 125 nmol/L)\n\nSome say higher\n\nhttps://www.hindawi.com/journals/dm/2015/864370/\n\n\nSerum concentrations, units\n\nNanograms per milliliter (ng/mL)\n\n(1000 ng = 1 microgram)\n\nNanomoles per liter (nmol/L)\n\n1 ng/mL is equal to 2.5 nmol/L\n\nSupplements\n\nMicrograms\n\nInternational units\n\n400 IU  = 10 mcg\n\n1,000 IU  = 25 mcg\n\n2,000 IU  = 50 mcg\n\n4,000 IU  = 100 mcg\n\n\nHow much to take in Winter?\n\nhttps://www.nhs.uk/conditions/vitamins-and-minerals/vitamin-d/\n\nDo not take more than 100 micrograms (4,000 IU) of vitamin D a day (11 years to adults)\n\nChildren aged 1 to 10 years should not have more than 50 micrograms (2,000 IU) a day. \n\nInfants under 12 months should not have more than 25 micrograms (1,000 IU) a day.\n\n\n\nProstate cancer\n\nhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1472821/\n\nColon cancer\n\nhttps://www.dana-farber.org/newsroom/news-releases/2019/high-dose-vitamin-d-shows-benefit-in-patients-with-advanced-colorectal-cancer/\n\nBreast cancer\n\nhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5802611/\n\nMultiple sclerosis\n\nhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5990512/\n\nHeart disease\n\nhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC2851242/\n\nImmunity\n\nhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3166406/\n\nAutoimmunity\n\nhttps://ard.bmj.com/content/70/9/1569\n\nDiabetes\n\nhttps://pubmed.ncbi.nlm.nih.gov/32080077/\n\n\nChronic pain and sleep\n\nhttps://pubmed.ncbi.nlm.nih.gov/22699141/\n\nDepression\n\nhttps://www.jneuropsychiatry.org/peer-review/depression-and-vitamin-d-deficiency-causality-assessment-and-clinical-practice-implications-12051.html\n\nCytokine storm\n\nhttps://www.medrxiv.org/content/10.1101/2020.04.08.20058578v4\n\nCOVID\n\nhttps://www.nhs.uk/conditions/coronavirus-covid-19/people-at-higher-risk/get-vitamin-d-supplements/", "link": "https://www.youtube.com/watch?v=uS2VObw1UeI", "date_published": "2021-02-12 00:00:00+00:00", "persistent": false, "user": null, "language": "en-US"}]